Table 2.
Demographic data of respondents
| Healthcare professionals (N = 190) | |
|---|---|
| Sex (N, %) | |
| Female | 99 (52) |
| Male | 91 (48) |
| Specialism (N, %) | |
| Cardiologist1 | 66 (35) |
| Intervention | 16 |
| Imaging | 23 |
| Heart failure | 12 |
| Electrophysiology and devices | 8 |
| Other | 9 |
| Medical oncologist | 29 (15) |
| Breast cancer | 10 |
| Gynecological | 4 |
| Urologic | 4 |
| Palliative care | 4 |
| Lung | 2 |
| Radiation oncologist | 66 (35) |
| Hematologist | 29 (15) |
| Work experience in years, median (IQR) | 10 (5–18.8) |
| Type of hospital (N, %) | |
| University medical center | 96 (51) |
| Top-clinical hospital2 | 70 (37) |
|
General hospital Private hospital |
22 (12) 2 (1) |
| Cardio-oncology unit at hospital (N, %) | |
| Yes | 75 (40) |
| No | 115 (60) |
| Completed PhD trajectory (N, %) | |
| Yes | 115 (60) |
| No | 75 (40)4 |
| Number of new cardio-oncology patients at outpatient ward per month (N, %)3 | |
| None | 18 (10) |
| 1–10 | 123 (65) |
| 11–20 | 37 (20) |
| 21–30 | 9 (5) |
| ≥ 30 | 3 (2) |
1Only certified subspecialties are provided, other non-certified subspecialties for cardiologists are devices, cardio-oncology, congenital heart disease, and cardiovascular disease in women
2A top-clinical hospital is a secondary care setting; these hospitals provide both basic and complex care
3Cardio-oncology patients were defined as oncology patients with traditional cardiovascular risk factors receiving cardiotoxic treatment or oncology patients with pre-existing cardiovascular disease
415 respondents were PhD candidates at the time of the study